Immunology and Allergy

This systematic review and meta-analysis evaluates the treatment-related adverse events of combining immune checkpoint inhibitors with angiogenesis inhibitors in advanced lung cancer. The study finds the adverse events to be...

The study explores the efficacy of Lenvatinib plus anti-PD-1 antibodies as a conversion therapy for patients with unresectable hepatocellular carcinoma, showing promising results and identifying pre-existing CD8(+) cells as a...